↓ Skip to main content

Dove Medical Press

Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence

Overview of attention for article published in OncoTargets and therapy, September 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
62 Mendeley